Cryoport
NAQ:CYRX · US2290503075
Life Sciences Tools & ServicesMedium
360
83
Value56
Quality57
Growth58
Safety59
Sentiment55
Value Creation10/20creating some value
- Creates more value than its capital costs
- Owner earnings growing
- Owner earnings per share growing
- Reinvests at strong returns
- Solid earnings base
What this means
Cryoport clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.
Profile
CountryUSA
IndustryLife Sciences Tools & Services
SizeMedium
TypePublic Company
ExchangeNASDAQCM
Employees271
Websitecryoport.com
ISINUS2290503075
Last UpdateApr 2, 2026
Indices
Themes
Freight ServiceHealth DiagnosticsPackaging ServicesClinical TrialsLogisticsShipping
Description
Analysis
Middle-of-the-road
Cryoport, Inc. sits in the middle of our grid: average quality, average price, no obvious signal in either direction.
360° rank · history
1007550250
68
2023202420252026
All-time high
68
Jun 2026
All-time low
15
Jan 2024
Average rank
43
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.
Similar Stocks
The companies this stock is ranked against.
Pacific Biosciences of California
NSQ:PACB
16
CountryUSA
IndustryLife Sciences Tools & Services
SizeSmall
Full Stock Analysis →
BioLife Slutn
NAQ:BLFS
50
CountryUSA
IndustryLife Sciences Tools & Services
SizeSmall
Full Stock Analysis →
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100